Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia

J. Parigger, C. M. Zwaan, D. Reinhardt, G. J. L. Kaspers

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)137-146
JournalExpert Review of Anticancer Therapy
Volume16
Issue number2
DOIs
Publication statusPublished - 1 Feb 2016

Keywords

  • Gemtuzumab ozogamicin
  • Mylotarg (R)
  • acute myeloid leukemia
  • children
  • efficacy
  • toxicity

Cite this